1. Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: Randomised study. (February 2015) Authors: Walker, Zuzana; Moreno, Emilio; Thomas, Alan; Inglis, Fraser; Tabet, Naji; Rainer, Michael; Pizzolato, Gilberto; Padovani, Alessandro Journal: British journal of psychiatry Issue: Volume 206:Number 2(2015) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evolution of clinical features in possible DLB depending on FP-CIT SPECT result. (6th September 2016) Authors: Walker, Zuzana; Moreno, Emilio; Thomas, Alan; Inglis, Fraser; Tabet, Naji; Stevens, Tim; Whitfield, Tim; Aarsland, Dag; Rainer, Michael; Padovani, Alessandro Journal: Neurology Issue: Volume 87:Number 10(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. [O1–12–01]: [18F]FLUTEMETAMOL AMYLOID SCANNING IN A PHASE III AMNESTIC MILD COGNITIVE IMPAIRMENT STUDY: ADDITIONAL INFLUENCE OF OTHER BIOMARKERS IN ESTIMATING RISK OF CONVERSION TO PROBABLE ALZHEIMERS DISEASE. (1st July 2017) Authors: Buckley, Chris J.; Inglis, Fraser; Cherubini, Andrea; Zanette, Michelle; Farrar, Gill; Brooks, David J.; Wolk, David A. Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 4 Page Start: P221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1‐264: GENERATION PROGRAM RECRUITMENT STRATEGY (ALZHEIMER DISEASE PREVENTION CLINICAL TRIALS) CARRIED OUT BY GLASGOW MEMORY CLINIC. (1st July 2019) Authors: Hendry, Kirsty; Lynch, Jennifer; Williamson, Susan; Lee, Emma; Wallace, Lorna; Cranmer, Alison; Main, Laura; Inglis, Fraser Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 6 Page Start: P340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O4‐06‐03: PREVALENCE OF DLB FEATURES IN POSSIBLE DEMENTIA WITH LEWY BODIES AND ITS RELATIONSHIP TO CHANGES IN DEMENTIA DIAGNOSTIC CATEGORY AFTER DOPAMINE TRANSPORTER IMAGING USING DATSCAN™. (1st July 2014) Authors: Walker, Zuzana; Rainer, Michael; Thomas, Alan; Tabet, Naji; Inglis, Fraser; Banica, Mihaela; Grachev, Igor D.; Moreno, Emilio; Padovani, Alessandro Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 4 Page Start: P262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P4‐272: THE RESEARCH LUMBAR PUNCTURE: FURTHER EVIDENCE OF SAFETY AND TOLERABILITY WHEN UNDERTAKEN BY EXPERIENCED ANAESTHETISTS. (1st July 2014) Authors: Inglis, Fraser; Sim, Malcolm; Lamb, Kenny; Lynch, Jennifer Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 15 Page Start: P884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P2–097: Changes in dementia diagnostic category and diagnostic confidence following dopamine transporter SPECT imaging (DaTscanTM ‐ Ioflupane 123I) in people with an uncertain diagnosis of dementia with Lewy bodies (possible DLB). (1st July 2013) Authors: Walker, Zuzana; Thomas, Alan; Tabet, Naji; Inglis, Fraser; Padovani, Alessandro; Pizzolato, Gilberto; Rainer, Michael; Moreno, Emilio Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 9 Page Start: P379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. APOE4 carrier identification, genetic disclosure and amyloid status: Results from the generation 2 program Alzheimer's disease prevention clinical trial at Glasgow Memory Clinic: Developing topics. (7th December 2020) Authors: Lynch, Jennifer; Hendry, Kirsty; Lee, Emma; Wallace, Lorna; Williamson, Susan; Main, Laura; Cranmer, Alison; Inglis, Fraser Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 10 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. Issue 7 (July 2021) Authors: Burns, Daniel K; Alexander, Robert C; Welsh-Bohmer, Kathleen A; Culp, Meredith; Chiang, Carl; O'Neil, Janet; Evans, Rebecca M; Harrigan, Patrick; Plassman, Brenda L; Burke, James R; Wu, Jingtao; Lutz, Michael W; Haneline, Stephen; Schwarz, Adam J; Schneider, Lon S; Yaffe, Kristine; Saunders, Ann ... Journal: Lancet neurology Issue: Volume 20:Issue 7(2021) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗